Please read and agree to the terms and conditions of this site.
@venturebeat.com 6 years ago
Augmenix to Unveil New Clinical Data on its Innovative Absorbable Hydrogel Technology at the 59th Annual Meeting of the American Society for Radiation Oncology
@venturebeat.com 6 years ago
Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications
@venturebeat.com 7 years ago
Seven Bridges Announces Scientific Advisory Board
@venturebeat.com 7 years ago
Phase 3 Trial Data Show Use of SpaceOAR® Hydrogel Helps Maintain Erectile Function Following Prostate Cancer Radiation Treatment
@venturebeat.com 7 years ago
Seven Bridges to Present on Cancer Moonshot’s Blood Profiling Atlas at Precision Medicine World Congress
@venturebeat.com 7 years ago
Augmenix Announces Positive Three-Year Long-Term Data Highlighting Benefits of SpaceOAR® Hydrogel Spacer for Patients with Prostate Cancer
@venturebeat.com 7 years ago
National Cancer Institute Extends Scope of Seven Bridges Cancer Genomics Cloud Pilot